Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Comprehensive pan-cancer analysis identified SLC16A3 as a potential prognostic and diagnostic biomarker

Fig. 1

Pan-cancer analysis of SLC16A3 expression. (A) SLC16A3 mRNA expression in TCGA cancers and GTEx normal tissues. (B) SLC16A3 mRNA expression in human cancers from the TCGA database analyzed by the TIMER2.0 database. (C) SLC16A3 mRNA expression level in paired tumor samples based on TCGA database. (*P < 0.05, **P < 0.01, ***P < 0.001)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us